Skip to main content
Signal8

WEST PHARMACEUTICAL SERVICES INC (WST)

West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.

Sector: Surgical & Medical Instruments & Apparatus

Industry: Medical - Instruments & Supplies

West Pharmaceutical Services, Inc. logo

West Pharmaceutical Services, Inc.

NYSE:WSTHealthcare
-0.48%$392.15
AH Close$392.15+0.00%vs close
Mkt Cap$27.6B
Float69.93M
O/S70.38M
Inst Own99.9%
Div Yield0.22%
Dilution
Historical Data
DateOpenHighLowCloseVolume
Key Metrics
Market Cap$27.60B
Enterprise Value--
P/E Ratio40.88
Est. Net Cash/Share--
Institutional Ownership99.86%

based on 70.38M shares outstanding

SectorHealthcare
IndustryMedical - Instruments & Supplies
ExchangeNYSE
CountryUSUS
IPO Date-
Shares Outstanding70.38M
Float69.93M
Company Overview

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.

It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components.

It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.

It serves pharmaceutical, diagnostic, and medical device companies.

The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.

Leadership

Annette F. Favorite

Chief Human Resources Officer & Senior Vice President

ERIC M. GREEN

Non-Independent Chair of the Board, President & Chief Executive Officer

Robert W. McMahon

Senior Vice President & Chief Financial Officer

Shane A. Campbell

SVP & Chief Proprietary Segment Officer

Employees

11K+

Country

US

Sector

Healthcare

Website

westpharma.com

Analyst Coverage
Analyst Coverage
ConsensusBuy
Price Target
No price targets available
Ratings Distribution
BUY
11
HOLD
3
SELL
1
TOTAL15
Insider Trading
InsiderTypeShares
HAUGEN JANET BRUTSCHEA profile photoHAUGEN JANET BRUTSCHEAGrant/Award44
Favorite Annette F profile photoFavorite Annette FSale2.5K
Favorite Annette F profile photoFavorite Annette FOption Exercise2.5K
Favorite Annette F profile photoFavorite Annette FOption Exercise2.5K
Favorite Annette F profile photoFavorite Annette FOption Exercise2.5K
Favorite Annette F profile photoFavorite Annette FOption Exercise2.5K
Shareholders
99.9%
Institutional
(854)
0.7%
Insiderⓘ
(23)
0.0%
5%+ Owners
(0)
-
Unattributed (incl. retail)ⓘ
Institutional99.9%
Insider0.7%
Sources: 13F, Form 4, 13D/13GO/S: 70.4M · as of 20 Jul 2026 · SEC cover page
Insiders & Institutional Holders
52-Week Range
$223.83$397.15
$392.15(97th percentile)
Volume
Average Daily Volume513.63K
718.05K today vs 513.63K avg(+40%)

30d Avg

513.63K

60d Avg

557.10K

90d Avg

553.64K

Earnings
Dividend History
TTM Yield
0.22%
Paid quarterly
Annual (LTM)
$0.88
Latest
$0.2600
Nov 10, 26
5Y Growth
+5.29%
per year
Compliance Status
Loading compliance data...